INTRODUCTION
REASONS FOR DOING THE STUDY
The objective of this study is to provide an in-depth analysis and forecast of the selected areas of the global healthcare-acquired infection (HAI) market. HAI is sometimes used to mean hospital-acquired infections, but for purposes of this report, HAI includes hospitals, nursing homes, outpatient surgery centers, and dialysis centers. Another term for healthcare-acquired infections is nosocomial infections.
The focus of this report is on devices, pharmaceuticals, and therapies currently used or under development for treatment of viral, bacterial, or fungal infections.
The global market for HAI products is estimated at between $10 billion and $15 billion in 2010, depending on the products included in the study, with high single-digit growth through 2016. Although the U.S. holds between 45% and 50% of the market, the fastest-growing regions for HAI treatments are the Asia-Pacific, which includes China, and Brazil.
STUDY GOALS AND OBJECTIVES
Healthcare-acquired infections are viral, bacterial, or fungal infections that patients acquire after they are admitted to a healthcare facility. Patients can acquire these infections from routine care; surgery; or as a complication from the use of medical devices such as ventilators, catheters, and intravenous lines.
The Centers for Disease Control (CDC) estimates that 2 million HAIs occur annually in the U.S. This leads to 100,000 deaths and costs an additional $36 billion to $45 billion in direct medical costs annually.
This report is designed to investigate the global HAI market by treatment area and by treatment type, with supporting tables and figures to illustrate projected growth. The report will include the U.S., Europe, Japan, and other countries such as China.
This report offers forecasts of the markets for devices, pharmaceuticals, and therapies by treatment segment and treatment type from 2011 through 2016, including supporting analyses for projections.
This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market. It provides background on the structure of the HAI market and the chief challenges and opportunities it faces. It offers the information needed to understand the current market and to address the emerging one.
This is an invaluable tool for business planners; acquisition specialists; licensing strategists; product managers; market research analysts; investing consultants; and others interested in the HAI market, its products, its participants, and its future.
METHODOLOGIES AND INFORMATION SOURCES
Information for this report was obtained from various primary and secondary research sources, including industry analysts, annual reports, Securities and Exchange Commission (SEC) reports, the World Health Organization (WHO), the National Institutes of Health (NIH), American Hospital Association (AHA), Infectious Disease Society of America (IDSA), American Society of Heating, Refrigerating and Air Conditioning Engineers (ASHRAE), National Institute of Allergy and Infectious Diseases (NIAID), the National Hospital Discharge Survey (NHDS), government agencies outside the U.S, and journal articles. Secondary sources include literature searches, product literature, and press releases.
When precise information was unavailable, a consensus is made using reasonable assumptions and estimates based on historical data.
ANALYST CREDENTIALS
Peggy S. Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder and an MS in Communication from the University of Denver. Ms. Lehr has worked in the publishing industry with both for-profit and not-for-profit organizations. She specializes in marketing reports on the medical industry.
BCC ONLINE SERVICES
BCC’s home page, located at www.bccresearch.com, enables readers to:
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
